Surface Oncology Current Cash

Surface Oncology (SURF) currently reports a current cash of $15M as of June 2023. That compares with $75M in the prior-year period — down 80.2% year over year. Use the charts on this page to explore Surface Oncology's current cash history and peer comparisons.

Surface Oncology's current cash decreased from $75M to $15M — a 80.2% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Surface Oncology reported $15M in current cash as of June 2023. That compares with $75M in the prior-year period — down 80.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $15M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Surface Oncology, and consider following SURF for alerts when major investors trade the stock.

Surface Oncology is classified in the Healthcare sector. On current cash, it currently shows $15M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SURF with unrelated industries.